258 related articles for article (PubMed ID: 8584618)
1. Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives.
Fiorella D; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 Oct; 121(3):357-63. PubMed ID: 8584618
[TBL] [Abstract][Full Text] [Related]
2. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis.
Fiorella D; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 Oct; 121(3):347-56. PubMed ID: 8584617
[TBL] [Abstract][Full Text] [Related]
3. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.
Fiorella D; Helsley S; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 Dec; 122(3):237-43. PubMed ID: 8748393
[TBL] [Abstract][Full Text] [Related]
4. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
Fantegrossi WE; Harrington AW; Eckler JR; Arshad S; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
Psychopharmacology (Berl); 2005 Sep; 181(3):496-503. PubMed ID: 15983786
[TBL] [Abstract][Full Text] [Related]
5. The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.
Fiorella D; Palumbo PA; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 May; 119(2):239-45. PubMed ID: 7659772
[TBL] [Abstract][Full Text] [Related]
6. Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM.
Eckler JR; Chang-Fong J; Rabin RA; Smith C; Teitler M; Glennon RA; Winter JC
Pharmacol Biochem Behav; 2003 Jul; 75(4):845-52. PubMed ID: 12957227
[TBL] [Abstract][Full Text] [Related]
7. Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.
Helsley S; Fiorella D; Rabin RA; Winter JC
Pharmacol Biochem Behav; 1998 Feb; 59(2):419-25. PubMed ID: 9476990
[TBL] [Abstract][Full Text] [Related]
8. LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex.
Arvanov VL; Liang X; Russo A; Wang RY
Eur J Neurosci; 1999 Sep; 11(9):3064-72. PubMed ID: 10510170
[TBL] [Abstract][Full Text] [Related]
9. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. III: The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion.
Fiorella D; Helsley S; Lorrain DS; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 Oct; 121(3):364-72. PubMed ID: 8584619
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
Gatch MB; Rutledge MA; Carbonaro T; Forster MJ
Psychopharmacology (Berl); 2009 Jul; 204(4):715-24. PubMed ID: 19288085
[TBL] [Abstract][Full Text] [Related]
11. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
[TBL] [Abstract][Full Text] [Related]
12. Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors.
Egan CT; Herrick-Davis K; Miller K; Glennon RA; Teitler M
Psychopharmacology (Berl); 1998 Apr; 136(4):409-14. PubMed ID: 9600588
[TBL] [Abstract][Full Text] [Related]
13. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
Mokler DJ; Commissaris RL; Warner MR; Rech RH
J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
[TBL] [Abstract][Full Text] [Related]
14. Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride.
Mokler DJ; Rech RH
Pharmacol Biochem Behav; 1984 Aug; 21(2):281-7. PubMed ID: 6483939
[TBL] [Abstract][Full Text] [Related]
15. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.
Halberstadt AL; Geyer MA
Psychopharmacology (Berl); 2010 Feb; 208(2):179-89. PubMed ID: 19937319
[TBL] [Abstract][Full Text] [Related]
16. Some behavioral effects of hallucinogens are mediated by a postsynaptic serotonergic action: evidence from single unit studies in freely moving cats.
Heym J; Rasmussen K; Jacobs BL
Eur J Pharmacol; 1984 May; 101(1-2):57-68. PubMed ID: 6745319
[TBL] [Abstract][Full Text] [Related]
17. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
Marek GJ; Aghajanian GK
J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
[TBL] [Abstract][Full Text] [Related]
18. A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine.
White FJ; Appel JB
Psychopharmacology (Berl); 1981; 73(2):110-5. PubMed ID: 6785800
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
Glennon RA; Young R; Rosecrans JA
Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740
[TBL] [Abstract][Full Text] [Related]
20. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
